Literature DB >> 18423892

Cochlear implantation and connexin expression in the child with keratitis-ichthyosis-deafness syndrome.

Yun-Hoon Choung1, You Ree Shin, Hyon J Kim, You Chan Kim, Jae Hong Ahn, Seong Jun Choi, Seong-Yong Jeong, Keehyun Park.   

Abstract

We report one child with keratitis-ichthyosis-deafness (KID) syndrome. The child showed sparse, short scalp and body hairs, ichthyotic skin, bilateral sensorineural hearing loss, and visual loss. These are associated with a nucleotide substitution, 148G>A, which results in amino acid change in codon 50 of gap junctional protein connexin (Cx) 26. Immunohistochemistry of skins showed up-regulation of Cx26 and down-regulation of Cx43. He has benefited from cochlear implantation for hearing even though low visual function and skin problems with high risk of infections. This is the very rare report about Cx expression in skins and cochlear implantation in KID syndrome.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423892     DOI: 10.1016/j.ijporl.2008.02.023

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

1.  Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis.

Authors:  Robert W Eppsteiner; A Eliot Shearer; Michael S Hildebrand; Adam P Deluca; Haihong Ji; Camille C Dunn; Elizabeth A Black-Ziegelbein; Thomas L Casavant; Terry A Braun; Todd E Scheetz; Steven E Scherer; Marlan R Hansen; Bruce J Gantz; Richard J H Smith
Journal:  Hear Res       Date:  2012-08-28       Impact factor: 3.208

2.  Cochlear Implantation in Patients with Keratitis-Ichthyosis-Deafness Syndrome: A Report of Two Cases.

Authors:  Birgul Gumus; Armagan Incesulu; Mehmet Ozgur Pinarbasli
Journal:  Case Rep Otolaryngol       Date:  2017-10-02

3.  Altered cellular localization and hemichannel activities of KID syndrome associated connexin26 I30N and D50Y mutations.

Authors:  Hande Aypek; Veysel Bay; Gülistan Meşe
Journal:  BMC Cell Biol       Date:  2016-02-02       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.